Global Liver Cancer Drug Pipeline Capsule - 2012

Fore Pharma, January 2012, Pages: 15

Fore Pharma’s latest report ‘Global Liver Cancer Drug Pipeline Capsule – 2012’ is an outline of all the key research and development (R&D) activities of the global Liver Cancer drug market. It covers information on key pipeline molecules in various stages of R&D including all the phases of clinical trials, preclinical research, and drug discovery. The report is up-to-date with full coverage of the licensing activities and partnerships.

This report helps executives to keep a track of their competitors and understand their pipeline molecules. The information presented in this report can be used for identifying the partners, prioritizing, evaluating opportunities, developing business development strategies, and executing in-licensing and out-licensing deals.

The report provides information on pipeline molecules by company and mechanism of action across the different stages of R&D. It includes registered / preregistered stage, phase 3 clinical trial, phase 2 clinical trial, phase 1 clinical trial, preclinical research, and drug discovery. It also provides information on pipeline molecules developed in leading geographies including the U.S., Canada, France, Germany, U.K., Italy, and Spain by various stages of R&D. Licensing activities and partnerships in the Liver Cancer drug market is thoroughly covered by company and licensee with the deal summary.

Key Features of the Report:
- Liver Cancer: Overview
- Liver Cancer Drug Pipeline Overview
- Liver Cancer Phase 3 Clinical Trial Drug Pipeline Insights
- Liver Cancer Phase 2 Clinical Trial Drug Pipeline Insights
- Liver Cancer Phase 1 Clinical Trial Drug Pipeline Insights
- Liver Cancer Preclinical Research Drug Pipeline Insights
- Liver Cancer Drug Discovery Pipeline Insights
- Geographic Landscape of Liver Cancer R&D Activities
- Liver Cancer R&D Activities in North America
- Liver Cancer R&D Activities in Europe
- Licensing Activities / Partnerships in the Global Liver Cancer Drug Market

1. Liver Cancer: Disease Definition
2. Liver Cancer Drug Pipeline Overview
3. Liver Cancer Phase 3 Clinical Trial Drug Pipeline Insights
4. Liver Cancer Phase 2 Clinical Trial Drug Pipeline Insights
5. Liver Cancer Phase 1 Clinical Trial Drug Pipeline Insights
6. Liver Cancer Preclinical Research Drug Pipeline Insights
7. Liver Cancer Drug Discovery Pipeline Insights
8. Geographic Landscape of Liver Cancer R&D Activities
8.1. Liver Cancer R&D Activities in North America
8.2. Liver Cancer R&D Activities in Europe
9. Licensing Activities / Partnerships in the Global Liver Cancer Drug Market
10. Research Methodology
Table 1: Liver Cancer Drug Pipeline: Phase 3 Clinical Trial Molecules
Table 2: Liver Cancer Drug Pipeline: Phase 2 Clinical Trial Molecules
Table 3: Liver Cancer Drug Pipeline: Phase 1 Clinical Trial Molecules
Table 4: Liver Cancer Drug Pipeline: Preclinical Research Molecules
Table 5: Liver Cancer R&D Activities by Geography
Table 6: Liver Cancer Drug Pipeline: North America
Table 7: Liver Cancer Drug Pipeline: Europe
Table 8: Liver Cancer Drug Pipeline: Licensing Activities
Figure 1 : Liver Cancer Drug Pipeline Molecules by Stages
Figure 2 : Liver Cancer R&D Activities by Geography

Customers who bought this item also bought

• Global Oncology Drug Pipeline Capsule – 2012
• Global Ovarian Cancer Drug Pipeline Capsule - 2012 Update
• Global Pancreatic Cancer Drug Pipeline Capsule - 2012 Update
• Global Renal Cancer Drug Pipeline Capsule - 2012 Update
• Global Oesophageal Cancer Drug Pipeline Capsule - 2012 Update
• Global Bladder Cancer Drug Pipeline Capsule - 2012 Update
• Global Brain Cancer Drug Pipeline Capsule - 2012 Update
• Global Breast Cancer Drug Pipeline Capsule - 2012 Update
• Global Cervical Cancer Drug Pipeline Capsule - 2012 Update
• Global Gastric Cancer Drug Pipeline Capsule - 2012 Update